Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ONC sponsoring Cgy Flames post game radio

<< Previous

Bullboard Posts

Next >>

Comment by 13X2413on Nov 01, 2023 9:21pm

150 Views

Post# 35712571

RE:RE:RE:RE:RE:RE:RE:RE:ONC sponsoring Cgy Flames post game radio

Advertising on the radio station is a perfect fit :)

"Sportsnet 960 the Fan has a male centric audience, genreally making up 75% of the stations listeners. These are affluent, often business owners, and are quy's guys - they like sports, cars, beer, good food and good times!"

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features